Screening for Islet Autoantibodies in Family Members of T1D Patients
A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients
Recruiting
Observational Study
Type 1 Diabetes
Autoantibodies Screening
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 2 – 45
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20,000 (estimated)
- Sponsor
- Rabin Medical Center · Other
Who this trial is looking for
This trial is looking for family members of people with type 1 diabetes to check for certain autoantibodies. If found, participants will receive education to help prevent further diabetes-related issues.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 2 and 45 years old.
- I am a first-degree relative of someone with type 1 diabetes.
- I can sign an informed consent.
You may not be able to join if
- I have known diabetes of any kind.
- I have been treated with insulin or oral diabetes medications.
- I am currently using systemic immunosuppressive agents.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A national Screening program for the presence of Islet Autoantibodies (IA) in relatives of people with type 1 diabetes (PWT1D) aiming at identifying people with pre-clinical (stage 1 \& 2) T1D and DKA prevention on the clinical presentation of T1D. All participants will be screened at study entry for the presence of 4 islet autoantibodies: glutamic acid decarboxylase antibody (GADA), insulinoma-as…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 2-45 years
* First-degree relatives of Type 1 Diabetes probands
* Signing an informed consent
Exclusion Criteria:
* Known diabetes of any kind (type 1, type 2, MODY)
* Have a previous history of being treated with insulin or oral diabetes medications.
* Currently, using …
Contacts